Search research articles
Contact Us
Filters
Showing results (151-160 of 227) with videos related to
Page
of 23
Sort By:
The Journal of Infectious Diseases
|
August 17, 2011
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy
Roger Paredes, Maria Carmen Puertas, Wendy Bannister, et al.
Frontiers in Public Health
|
June 28, 2021
A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy
Francesca Bai, Alessandro Tavelli, Giovanni Mulè, et al.
The Journal of Antimicrobial Chemotherapy
|
September 25, 2018
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART
Francesca Ceccherini-Silberstein, Alessandro Cozzi Lepri, Claudia Alteri, et al.
Plos One
|
May 19, 2017
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort
Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Francesca Ceccherini-Silberstein, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 4, 2003
Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study
Rita Murri, Alessandro Cozzi Lepri, Andrew N Phillips, et al.
The Journal of Antimicrobial Chemotherapy
|
February 24, 2026
Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomes
Laura Pezzati, Federico Conti, William Gennari, et al.
Frontiers in Immunology
|
April 7, 2022
Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival
Lara Gibellini, Sara De Biasi, Marianna Meschiari, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 8, 2024
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022
Annalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 4, 2003
Virologic correlates of adherence to antiretroviral medications and therapeutic failure
Carlo Federico Perno, Francesca Ceccherini-Silberstein, Andrea De Luca, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
January 8, 2015
Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort
Monica Tontodonati, Giovanni Cenderello, Benedetto Maurizio Celesia, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 227) with videos related to
Sort By:
Page
of 23
The Journal of Infectious Diseases
|
August 17, 2011
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy
Roger Paredes, Maria Carmen Puertas, Wendy Bannister, et al.
Frontiers in Public Health
|
June 28, 2021
A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy
Francesca Bai, Alessandro Tavelli, Giovanni Mulè, et al.
The Journal of Antimicrobial Chemotherapy
|
September 25, 2018
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART
Francesca Ceccherini-Silberstein, Alessandro Cozzi Lepri, Claudia Alteri, et al.
Plos One
|
May 19, 2017
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort
Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Francesca Ceccherini-Silberstein, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 4, 2003
Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study
Rita Murri, Alessandro Cozzi Lepri, Andrew N Phillips, et al.
The Journal of Antimicrobial Chemotherapy
|
February 24, 2026
Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomes
Laura Pezzati, Federico Conti, William Gennari, et al.
Frontiers in Immunology
|
April 7, 2022
Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival
Lara Gibellini, Sara De Biasi, Marianna Meschiari, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 8, 2024
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022
Annalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 4, 2003
Virologic correlates of adherence to antiretroviral medications and therapeutic failure
Carlo Federico Perno, Francesca Ceccherini-Silberstein, Andrea De Luca, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
January 8, 2015
Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort
Monica Tontodonati, Giovanni Cenderello, Benedetto Maurizio Celesia, et al.
Page
of 23